EUVIMEDEUVIMED entdecken
Multizentrische StudieOpen Access · CC BY-NC-ND 4.0

Molecular analysis using SalvGlandDx improves risk of malignancy estimation and diagnosis of salivary gland cytopathology: An exploratory multicenter study

Sandra N Freiberger iD, Kristian Ikenberg, Demi van Egmond, Sofie Claerhout, Tom van Wezel, Isabelle Vanden Bempt, Jeroen N van Rossem, Simon A Mueller, Paul M Clement, Vincent Vander Poorten, Danielle Cohen, Esther Hauben und 1 weitere

Cancer Cytopathology · 2024

DOI: 10.1002/cncy.22814 ↗

Kurz gefasst

Multizentrische Studie in der Zeitschrift Cancer Cytopathology, 2024. Verfasst von Sandra N Freiberger und 12 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pathology and Molecular Pathology, University Hospital Zurich, Zurich, Switzerland. Hauptthemen laut MEDLINE: Salivary Gland Neoplasms. Die Arbeit wurde bisher 17-mal zitiert (Crossref) und nennt 35 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Hoofd- en halskankerfonds Walter Vandeputte - KU Leuven, Iten-Kohaut Foundation, Kurt and Senta Herrmann Foundation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Diagnosis of salivary gland neoplasms is challenging, especially on cytological specimens acquired by fine‐needle aspiration. The recently implemented standardized Milan system for reporting salivary gland cytopathology provides an estimated risk of malignancy (ROM); yet, for two of the categories, the diagnosis of the lesion remains unclear. However, a precise diagnosis is desirable for optimal patient management, including planning of surgery and imaging procedures.

Methods

Cytological specimens ( n = 106) were subjected to molecular analysis using the SalvGlandDx panel. The risk of malignancy was calculated for each detected alteration based on the diagnosis of the resection specimen. By taking into account the molecular alterations, their associated ROM, the clinical and cytological features, and the current literature, the Milan category was evaluated.

Results

Of n = 63 technically valid cases, 76% revealed a molecular alteration. A total of 94% of these molecularly altered cases could be assigned to a different Milan category when additionally taking molecular results into account. In only 2% of the salivary gland neoplasms of uncertain malignant potential, in which a molecular alteration was detected, the classification remained salivary gland neoplasms of uncertain malignant potential.

Conclusion

Molecular analysis of cytological specimens provides a benefit in classifying salivary gland neoplasms on fine‐needle aspiration. It can improve the ROM estimation and thus help to assign cases of formerly unknown malignant potential to clearly benign or malignant categories.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Salivary Gland NeoplasmsHumansBiopsy, Fine-NeedleMaleFemaleMiddle AgedAdultAgedAged, 80 and overYoung AdultBiomarkers, TumorSalivary GlandsCytodiagnosisRisk Assessment

Stichwörter der Autor:innen

cytologymolecular analysissalivary gland neoplasm

Substanzen

Biomarkers, Tumor

Autor:innen und Institutionen

  • Department of Pathology and Molecular Pathology, University Hospital Zurich, Zurich, Switzerland.
  • Department of Pathology, Leiden University Medical Center, Leiden, Netherlands.
  • Department of Human Genetics, University Hospitals Leuven, Leuven, Belgium.
  • Department of Otorhinolaryngology, Head and Neck Surgery, University Hospital Zurich, Zurich, Switzerland.
  • Department of Oncology, Section Experimental Oncology, Leuven Cancer Institute, KU Leuven, Leuven, Belgium.
  • Otorhinolaryngology-Head and Neck Surgery, University Hospitals Leuven, Leuven Cancer Institute, Leuven, Belgium.

ORCID-Profile: Sandra N Freiberger

Förderung

  • Hoofd- en halskankerfonds Walter Vandeputte - KU Leuven
  • Iten-Kohaut Foundation
  • Kurt and Senta Herrmann Foundation
  • Zurich Cancer League

Zitieren

APA

Freiberger, S. N., Ikenberg, K., van Egmond, D., Claerhout, S., van Wezel, T., Bempt, I. V., van Rossem, J. N., Mueller, S. A., Clement, P. M., Poorten, V. V., Cohen, D., Hauben, E., & Rupp, N. J. (2024). Molecular analysis using SalvGlandDx improves risk of malignancy estimation and diagnosis of salivary gland cytopathology: An exploratory multicenter study. Cancer Cytopathology. https://doi.org/10.1002/cncy.22814

Vancouver

Freiberger SN, Ikenberg K, van Egmond D, Claerhout S, van Wezel T, Bempt IV, et al. Molecular analysis using SalvGlandDx improves risk of malignancy estimation and diagnosis of salivary gland cytopathology: An exploratory multicenter study. Cancer Cytopathology. 2024. doi:10.1002/cncy.22814

BibTeX
@article{Freiberger2024,
  author = {Freiberger, Sandra N and Ikenberg, Kristian and van Egmond, Demi and Claerhout, Sofie and van Wezel, Tom and Bempt, Isabelle Vanden and van Rossem, Jeroen N and Mueller, Simon A and Clement, Paul M and Poorten, Vincent Vander and Cohen, Danielle and Hauben, Esther and Rupp, Niels J},
  title = {Molecular analysis using SalvGlandDx improves risk of malignancy estimation and diagnosis of salivary gland cytopathology: An exploratory multicenter study},
  journal = {Cancer Cytopathology},
  year = {2024},
  doi = {10.1002/cncy.22814}
}
Kostenlos starten →